Soria JC - Search Results

1

Gefitinib Plus Chemotherapy Versus Chemotherapy in Epidermal Growth Factor Receptor Mutation-Positive Non-Small-Cell Lung Cancer Resistant to First-Line Gefitinib (IMPRESS): Overall Survival and Biomarker Analyses.

Mok TSK, Kim SW, Wu YL, Nakagawa K, Yang JJ, Ahn MJ, Wang J, Yang JC, Lu Y, Atagi S, Ponce S, Shi X, Rukazenkov Y, Haddad V, Thress KS, Soria JC. Mok TSK, et al. Among authors: soria jc. J Clin Oncol. 2017 Dec 20;35(36):4027-4034. doi: 10.1200/JCO.2017.73.9250. Epub 2017 Oct 2. J Clin Oncol. 2017. PMID: 28968167 Clinical Trial.

2

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

Soria JC, Fizazi K, Piron D, Kramar A, Gerbaulet A, Haie-Meder C, Perrin JL, Court B, Wibault P, Théodore C. Soria JC, et al. Ann Oncol. 1997 Nov;8(11):1089-98. doi: 10.1023/a:1008248319036. Ann Oncol. 1997. PMID: 9426328 Free article.

3

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer.

Fizazi K, Ducreux M, Ruffié P, Bonnay M, Daniel C, Soria JC, Hill C, Fandi A, Poterre M, Smith M, Armand JP. Fizazi K, et al. Among authors: soria jc. J Clin Oncol. 2000 Jun;18(11):2293-300. doi: 10.1200/JCO.2000.18.11.2293. J Clin Oncol. 2000. PMID: 10829050 Clinical Trial.

4

Do all patients with advanced non-small-cell lung cancer benefit from cisplatin-based combination therapy?

Soria JC, Brisgand D, Le Chevalier T. Soria JC, et al. Ann Oncol. 2001 Dec;12(12):1667-70. doi: 10.1023/a:1013574413217. Ann Oncol. 2001. PMID: 11843242 Free article. Clinical Trial.

5

Lack of PTEN expression in non-small cell lung cancer could be related to promoter methylation.

Soria JC, Lee HY, Lee JI, Wang L, Issa JP, Kemp BL, Liu DD, Kurie JM, Mao L, Khuri FR. Soria JC, et al. Clin Cancer Res. 2002 May;8(5):1178-84. Clin Cancer Res. 2002. PMID: 12006535

6

hTERT expression is a prognostic factor of survival in patients with stage I non-small cell lung cancer.

Wang L, Soria JC, Kemp BL, Liu DD, Mao L, Khuri FR. Wang L, et al. Among authors: soria jc. Clin Cancer Res. 2002 Sep;8(9):2883-9. Clin Cancer Res. 2002. PMID: 12231532

7

Lack of interleukin-10 expression could predict poor outcome in patients with stage I non-small cell lung cancer.

Soria JC, Moon C, Kemp BL, Liu DD, Feng L, Tang X, Chang YS, Mao L, Khuri FR. Soria JC, et al. Clin Cancer Res. 2003 May;9(5):1785-91. Clin Cancer Res. 2003. PMID: 12738735

8

Breast metastasis from lung adenocarcinoma: a case report.

Masmoudi A, Mathieu MC, Soria JC. Masmoudi A, et al. Among authors: soria jc. Anticancer Res. 2003 Mar-Apr;23(2C):1825-6. Anticancer Res. 2003. PMID: 12820464

9

Chemoprevention of lung cancer.

Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Soria JC, et al. Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0. Lancet Oncol. 2003. PMID: 14602246 Review.

10

[Therapeutic implications of epidermal growth factor receptor in lung cancer].

Fayette J, Le Chevalier T, Soria JC. Fayette J, et al. Among authors: soria jc. Bull Cancer. 2003 Nov;90 Spec No:S233-40. Bull Cancer. 2003. PMID: 14763145 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters